Expression of the PTEN tumor suppressor gene is abnormal in many human cancers. Loss of PTEN expression leads to the activation of downstream signaling pathways that have been associated with resistance to radiation. In non-small cell lung carcinoma (NSCLC), suppressed expression of PTEN is frequently due to methylation of its promoter region. In this study, we tested whether gene transfer of wild-type PTEN into an NSCLC cell line with a known methylated PTEN promoter, H1299, would increase its sensitivity to ionizing radiation. Pretreating H1299 cells with an adenoviral-mediated PTEN (Ad-PTEN)-expressing vector sensitized H1299 cells to radiation. To determine the mechanism responsible for radiosensitization, we first examined radiation-induced apoptosis, which was enhanced but did not correlate with radiosensitizing effect of Ad-PTEN. Therefore, we next examined the ability of Ad-PTEN to modulate the repair of radiation-induced DNA double-strand breaks (DSBs) using the detection of repair foci positive for g-H2AX, a protein that becomes evident at the sites of each DSB and that can be visualized by immunofluorescent staining. Compared with controls, the repair of radiation-induced DSBs was retarded in H1299 cells pretreated with Ad-PTEN, consistent with the radiosensitizing effect of the vector. We conclude that signal transduction pathways residing primarily in the cytoplasm may intersect with DNA damage and repair pathways in the nucleus to modulate cellular responses to radiation. Elucidating the mechanisms responsible for this intersection may lead to novel strategies for improving therapy for cancers with defective PTEN.
Introduction
The success of radiotherapy for cancer has been shown to correlate with tumor-cell radiosensitivity, 1, 2 suggesting that tumors that fail to respond to radiation may be relatively resistant; however, the mechanisms for this radioresistance are unknown. The process of oncogenic transformation often involves the activation of molecular pathways that render the resultant tumor more tolerant of radiation than cells in the normal tissue of the patient. Thus, resistance of tumor cells to radiation could be due to abnormal functioning of these signaling pathways, many of which have not been well defined.
One such pathway is the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway. First identified as an oncogene, 3 Akt is activated through a PI3K-dependent pathway 4 by growth factors such as insulin, plateletderived growth factor, epidermal growth factor and basic fibroblast growth factor. 5 Increased Akt activity has been correlated with increased proliferation, metabolism, cellular migration, apoptosis resistance and survival signaling normally dependent on growth factors. 6, 7 For example, Akt is capable of phosphorylating and inactivating the proapoptotic proteins Bad 8, 9 and caspase-9. 10 Activated Akt has also been shown to induce a radioprotective effect. Inhibitors of PI3K, such as wortmannin and LY294002, which block Akt activation, have been shown to radiosensitize a variety of cell types. [11] [12] [13] In nonsmall cell lung carcinomas (NSCLC) in which Akt is typically abnormally activated, pretreatment with wortmannin increased apoptosis and reduced clonogenic cell survival in response to irradiation. 14 Neither wortmannin nor LY294002 is a clinically useful agent. An alternative strategy for the suppression of Akt activity has been to restore PTEN (phosphatase and tensin homologue deleted on chromosome 10) expression in PTEN-deficient tumor cells using gene therapy approaches. PTEN is a tumor suppressor gene estimated to be inactivated in 60% of solid tumors, including glioma, prostate carcinoma, melanoma, endometrial carcinoma and lung carcinoma. It was initially identified by virtue of its frequent deletion at chromosome 10q23 in glioblastomas and advanced prostate cancers. [15] [16] [17] PTEN functions by dephosphorylating phosphotyrosyl and phophoseryl/threonyl residues of proteins and the 3 0 position of the inositol ring of the lipid second-messenger PI(3,4,5)P3. 18 PTEN thus works in opposition to the activity of PI3K, thereby leading to the suppression of Akt activity. Wick et al. 19 showed that transfer of the wild-type PTEN gene radiosensitized PTEN-deficient malignant glioma cells while promoting the dephosphorylation of Akt.
In a previous report, we showed that adenoviralmediated PTEN (Ad-PTEN) radiosensitized PTENdeficient human prostate carcinoma cells. 20 Mutations in PTEN are relatively frequent in prostate cancer, but its status in NSCLC has been studied less often. One study found that abnormalities of the PTEN gene were involved in only a small subset of lung cancers. 21 However, a more recent report showed that lack of PTEN expression in NSCLC in many cases was due to promoter methylation. 22 In the current report, we present the results of tests conducted to determine whether Ad-PTEN can radiosensitize an NSCLC cell line in which the PTEN promoter is known to be methylated. To determine the mechanism whereby radiosensitization occurs, we also examined the effects of Ad-PTEN on the repair of radiation-induced DNA double-strand breaks (DSBs).
Materials and methods

Cell culture
The human NSCLC cell line H1299, which has been reported to not express PTEN due to methylation of the PTEN promoter, 22 was evaluated for radiosensitivity before and after PTEN transduction. H1299 cells were incubated in a humidified environment with 5% CO 2 -95% air at 371C in RPMI 1640 medium. The medium was supplemented with 10% fetal bovine serum (FBS), 100 units/ml penicillin-streptomycin, and 2 mM L-glutamine.
Transduction PTEN was delivered via a replication-defective type V adenovirus, Ad5CMV-PTEN (Introgen Therapeutics Inc., Austin, TX). The adenovirus was modified with an E1A/E1B deletion (bp 457-3332) and a small E3 deletion (bp 30 000-30 750). The E1 region of the recombinant adenovirus was replaced by the PTEN expression cassette, which contained a CMV promoter and an SV40 polyadenylation signal. 23 The transduction efficiency of the virus was determined using an identical construct, except that the PTEN gene was replaced by a LacZ gene. Positive (blue-staining) cells were visualized by adding X-Gal (5-bromo-4-chloro-3-indolyl-D-galactoside) 48 h after transduction and then scored. Sufficient vector was used to obtain transduction of 80% of cells based on X-Gal staining. ) was washed with 5 ml phosphate-buffered saline (PBS) and then incubated at 371C in 1 ml serum-free medium with purified vector for 1 h, with gentle rocking every 10 min. Four milliliters of fresh medium containing 10% FBS was then added. H1299 cells were transfected with 500 viral particles (vp)/cell.
Clonogenic survival assay
Forty-eight hours after transduction, nonconfluent cultures of H1299 cells were irradiated using a 137 Cs source (3.5 Gy/min) at room temperature. Cells were trypsinized and counted and known numbers were seeded onto 10-cm dishes in triplicate. The dishes and flasks were then returned to the incubator and allowed to grow macroscopic colonies undisturbed for 14 days. Colonies were stained with crystal violet and counted if they contained more than 50 cells. The plating efficiency and survival of cells irradiated at doses of 0, 2 and 4 Gy were calculated as percentages; plating efficiency was calculated relative to that in untransfected controls and survival was calculated relative to that in unirradiated cells. These experiments were repeated three to five times for control cells, cells mock transfected with Ad-Luc and Ad-PTEN-transfected cells.
Apoptosis detection and cell cycle analysis
Apoptosis was measured using the APO-BRDU apoptosis detection kit (PharMingen, San Diego, CA). Cells (2 Â 10 6 ) were fixed with 1% paraformaldehyde in PBS for 15 min at room temperature, washed twice with PBS, and stored at À201C in 70% ethanol overnight. Fluorescence-labeled anti-BRDU antibody was added, and the cells were incubated in the dark overnight at room temperature. Thirty minutes before analysis, cells were rinsed with PBS, and propidium iodide/RNase A was added as a counterstain for total DNA, indicating the cell cycle stage and sub-G 0 /G 1 populations. Stained cells were analyzed using an EPICS flow cytometer (Coulter Corp., Hialeah, FL).
Antibodies
Antibodies for phospho-Akt (Ser 473), phospho-Bad (Ser 136), PTEN and actin were purchased from Cell Signaling Technology (Danvers, MA). Antibodies for total Akt were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-rabbit and anti-mouse HRP-conjugated secondary antibodies were purchased from Amersham Pharmacia Biotech (Piscataway, NJ), and anti-goat HRPconjugated secondary antibody was purchased from Sigma Chemical Co. (St Louis, MO).
Western blotting
At 48 h after transfection, approximately 4 Â 10 6 cells were collected by trypsinization and resuspended in 75 ml cell lysis buffer (20 mM HEPES-KOH (pH 7.5), 10 mM KCl, 1.5 mM MgCl 2 , 1 mM sodium EDTA, 1 mM sodium EGTA, 250 mM sucrose, 50 mM NaF, 1 mM sodium orthovanadate and complete mini protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN). The lysate was incubated on ice for 10 min, homogenized in a microfuge tube by 40 strokes with a pestle and incubated on ice for another 10 min. Homogenates were centrifuged at 1000 g at 41C for 10 min. The supernatant was used in a protein assay to ensure equal loading and in western blot experiments at 20 mg/lane. Proteins were separated electrophoretically on SDS-polyacrylamide gels, and transferred onto polyvinylidene difluoride membranes (Millipore, Billerice, MA). Membranes were blocked for 3 h at room temperature in 5% milk-TBS-T (50 mM Trisbuffered saline (pH 7.6) containing 0.1% Tween-20). Primary antibodies were incubated at a 1:1000 dilution overnight in 5% milk-TBS-T at 41C. Membranes were washed with TBS-T three times, for 10 min each, and then incubated for 2 h at room temperature with horseradish peroxidase-conjugated secondary antibody at a 1:2000 dilution. Membranes were washed with TBS-T three times, for 10 min each, and proteins were detected by chemiluminescence using the ECL plus Western Blotting Detection System (Amersham Biosciences, Arlington Heights, IL) on a Storm 860 scanner (Amersham Biosciences, Piscataway, NJ).
Immunofluorescence Cells were grown overnight on cover slips in 35-mm dishes and transfected as described above. Dishes were irradiated with the 137 Cs source at a dose of 1.0 Gy. At 0, 0.25, 1, 2, 12 and 24 h after irradiation; medium was aspirated and the cells were washed with PBS for 5 min. All steps were conducted at room temperature. Cells were fixed with 1% paraformaldehyde for 10 min and then 70% ethanol for 10 min. Cells were incubated in 0.1% Nonidet P-40 in PBS for 20 min. Cells were washed with PBS twice, for 5 min each. Blocking buffer (5% BSA) was then applied for 30 min. Primary antibody for g-H2AX (Trevigen, Gaithersburg, MD) at a 1:300 dilution in 5% bovine serum albumin (BSA)-PBS was added for 2 h and then washed with PBS four times, for 10 min each. Secondary antibody (FITC-conjugated anti-rabbit in 5% BSA-PBS) was added for 30 min and then the cells were washed with PBS four times, for 10 min each. DAPI was applied for 5 min before the last wash. Cover slips were removed and sealed onto slides with Slow-Fade Light Anti-Fade (Molecular Probes, Eugene, OR). Decreased clonogenic survival due to PTEN transduction The toxicity of adenoviral treatment and PTEN transduction in the absence of irradiation was assessed on the basis of plating efficiency. The plating efficiency of H1299 was reduced from 52.6 to 36.0% and 23.5% by Ad-Luc and Ad-PTEN, respectively. These plating efficiencies were used to normalize radiation dose-response curves. As shown in Figure 2 , Ad-PTEN sensitized the H1299 cells to radiation. The surviving fraction of cells after administration of 2 Gy was reduced from 64.7% (control) and 69.4% (Ad-Luc) to 54.1% (Ad-PTEN). This effect was more dramatic after 4 Gy, where survival was reduced from 34.4% (control) and 40.6% (Ad-Luc) to 21.6% (Ad-PTEN). The differences in survival between cells transfected with Ad-PTEN and those left untreated or transfected with Ad-Luc were statistically significant (Po0.05) at both doses of radiation. Ad-Luc did not confer significant radiosensitivity.
Results
PTEN and Akt status
PTEN enhancement of radiation-induced apoptosis H1299 cells did undergo apoptosis after PTEN transduction. H1299 cells transfected with Ad-PTEN were 7.0% terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL)-positive at 24 h, compared with 4.3% of Ad-Luc-treated cells and 1.6% of control cells. At 48 h after treatment, 14.1% of the PTENtransduced H1299 cells were TUNEL-positive, whereas only 5.1% of the Ad-Luc and 1.5% of the controls were apoptotic. At 72 h, 9.2% of Ad-PTEN cells were TUNEL-positive, compared with 4.7% of the Ad-Luc cells and 1.3% of the controls (Figure 3) . At 48 and 72 h after irradiation, H1299 cells displayed increased apoptosis if they had been transduced with Ad-PTEN (Figure 4) . At 48 h after irradiation, 18.8% of Ad-Luc cells were TUNEL-positive compared to 37.9% of Ad-PTEN cells.
One mechanism by which the PTEN-PI3K-Akt pathway may regulate apoptosis is through the phosphorylation status of BAD. 24 BAD was one of the first targets of Akt to be identified with implications for cell survival. Controls were mock transfected. Total cellular proteins were harvested and subjected to western blot analysis for pAkt or PTEN. Actin was used as loading control.
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When BAD is phosphorylated by pAkt, it is no longer able to bind to Bcl-2 and inhibit its anti-apoptotic activity. Thus, restoration of PTEN expression should lead to lower levels of pAkt and pBAD thereby enhancing apoptosis. We examined the phosphorylation status of Bad and Akt in H1299 cells after Ad-PTEN transduction and found that both pAkt and pBAD were decreased by Ad-PTEN ( Figure 5 ). This response was correlated with the increase in apoptosis seen in Figures 3 and 4. PTEN retardation of DNA repair Ionizing radiation produces DNA DSBs that are primarily repaired by the non-homologous end joining repair pathway. An initial step in recognition of DSB is the phosphorylation of the histone H2AX at serine 139. g-H2AX foci form at a 1:1 ratio to DSBs at the site of the broken ends of DNA, making the number of foci a reliable marker for DSB formation and their subsequent disappearance a measure of repair. 25 The rate of DSB repair predicts the relative sensitivity of a cell to radiation. 26 Here, the repair of DBSs created by ionizing radiation was tracked by counting the number of phosphorylated g-H2AX foci per cell at several times in the 24 h following irradiation. In H1299 cells, the repair of DSBs was retarded after Ad-PTEN transduction. Fifteen minutes after a 1 Gy exposure, the cells had an average of 36 (control), 37.3 (Ad-Luc) and 37.5 (Ad-PTEN) foci/cell. By 2 h after irradiation, the phosphorylated foci in control and Ad-Luc-transduced cells were mostly repaired, with 7.6 and 4.8 foci/cell, respectively, but there were still an average of 25.3 foci/cell in the Ad-PTEN-treated cells. At 24 h, control cells had an average of 1.9 foci/cell, Ad-Luctreated cells 2.4 foci/cell and Ad-PTEN-treated cells 7.9 foci/cell ( Figure 6 ).
Discussion
In this study, we have shown that restoring PTEN by means of gene transfer in PTEN-defective NSCLC cells sensitizes them to radiation treatment. PTEN is a potent tumor suppressor gene that is frequently inactivated in many different types of human cancer. It is thought by some to be the second most commonly mutated tumor suppressor gene in human tumors, after p53. 27 Loss of PTEN function, either by mutation, deletion or gene methylation (as in the case of NSCLC cells), leads to Figure 3 Analysis of apoptosis induction after mock irradiation. H1299 cells were either transfected with Ad-Luc or Ad-PTEN 48 h before mock irradiation. Controls were mock transfected. Samples were taken at various times after the mock irradiation and analyzed for apoptosis, which was quantified on the basis of TUNEL positivity. Each data point represents the mean7s.e. of three or more independent determinations. The TUNEL positive values induced by Ad-PTEN were statistically significant compared to untreated controls at 24 and 72 h, P ¼ 0.0002 and P ¼ 0.02, respectively. persistent activation of Akt and its downstream substrates. Loss of PTEN by itself may be insufficient to cause cell transformation, but it was recently shown that mice bearing hematopoietic cells from which PTEN had been deleted developed transplantable leukemias within weeks. 28 Thus, the PTEN-PI3K-Akt pathway has become a critical target for inhibition in cancer therapeutics, and although small-molecule inhibitors are under development, gene therapy approaches also deserve consideration. As we have shown here, adenoviralmediated restoration of PTEN in PTEN-defective NSCLC cells induces apoptosis directly and sensitizes the cells to radiation, presumably by retarding the repair of radiation-induced DSBs. After receiving a dose of 1 Gy, samples were taken at various times and analyzed for g-H2AX foci using immunofluorescence microscopy as described in Materials and methods. Each data point represents the mean7s.e. for 100 cells scored.
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Although apoptosis generally does not occur in human tumor cells irradiated in vitro, we conducted tests to determine whether Ad-PTEN would restore radiationinduced apoptosis in the H1299 cells. Not only did the Ad-PTEN-pretreated cells show a tendency for increased radiation-induced apoptosis, but the Ad-Luc-pretreated cells did as well. However, because Ad-Luc did not lead to radiosensitization (as indicated by clonogenic survival), we concluded that the ability of Ad-PTEN to enhance radiation-induced apoptosis did not explain its radiosensitizing effects and therefore sought other explanations.
Ionizing radiation kills cells primarily by inducing DSBs. Although these breaks are resealed by complex repair processes, both the rate and extent of DSB repair correlates with cell radiosensitivity, that is, impeded DSB repair, as evidenced by the retention of g-H2AX foci over the first 24 h after irradiation, correlates with enhanced radiosensitization. 29, 30 As shown here, in Ad-PTENpretreated cells, but not in Ad-Luc-pretreated cells, the repair of radiation-induced DSBs was retarded. All the cells incurred an equivalent number of initial DSB, approximately 37 per cell, as determined by detecting and quantifying g-H2AX foci 15 min after irradiation. The majority of radiation-induced DNA DSBs were repaired after 2 h in untreated and Ad-Luc-treated cells, which then had 7.6 and 4.8 foci/cell, respectively. The Ad-PTEN cells still had an average of 25.3 foci/cell at this time point. This retardation in the rate of repair in Ad-PTEN-treated cells remained for at least 24 h, at which time there were four times more unrepaired breaks in the Ad-PTEN-treated cells (7.9 foci/cell) than in control and Ad-Luc-treated cells (with 1.9 and 2.4 foci/cell, respectively) ( Figure 6 ).
Prior reports have indicated that restoring PTEN function in PTEN-defective cells using gene transfer approaches radiosensitizes human glioma 19 and prostate carcinoma 20 cells. The molecular mechanism responsible for the radiosensitizing properties of Ad-PTEN has not been known, and the ability of Ad-PTEN to retard the repair of radiation-induced DSBs, shown here, has not been demonstrated before. The control of radiosensitivity by the PTEN-PI3K-Akt pathway has been generally appreciated, and PI3K inhibitors such as wortmanin and LY294002 have been shown to restore radiosensitivity in correlation with a suppression of DSB repair. 31, 32 However, the effectiveness of these inhibitors does not prove that the PTEN-PI3K-Akt pathway plays a role in governing the capacity for DSB repair because both are also known to directly inhibit DNA-PK, another member of the PI3K family of proteins and a key enzyme involved in DSB repair. 12 The connection between the PTEN-PI3K-Akt signaling pathway and the DSB repair pathways is not understood. A recent paper reported that the loss of PTEN caused sequestration of Chk1, a protein kinase that is activated upon DNA damage and that signals cell cycle arrest, from the nucleus. 33 In PTEN-defective cells, activated Akt phosphorylates Chk1, thereby inactivating its normal function. This recent finding, coupled with our results presented here, supports the notion that signal transduction pathways (such as the PTEN-PI3K-Akt pathway) that reside in the cytoplasm may intersect with DNA damage recognition and repair pathways in the nucleus and modulate the cellular response to genomic injury. Understanding these interactions will continue to be of priority in designing effective treatment strategies for human cancers that have defects in PTEN. However, as we have shown here, restoration of PTEN by gene transfer may have efficacy especially when combined with radiotherapy.
